Schedule 13G ownership disclosure

OnKure Therapeutics, Inc.

Class A Common Stock, par value $0.0001 per share · CUSIP: 68277Q105

Event date: 2025-12-31

Filing-level shares
542,361.00
Percent of class
4.2%
  • Highbridge Capital Management, LLC

    Shares: 542,361.00 · Class: 4.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-26-001088
Form type
SCHEDULE 13G/A
Filer
HIGHBRIDGE CAPITAL MANAGEMENT LLC
CIK
CIK 919185
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub